Comparative Study
doi: 10.1111/j.2042-7158.1987.tb06975.x.
Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1 alpha production and on bile salt-induced changes in gastric mucosal function
Affiliations
- PMID: 2445949
- DOI: 10.1111/j.2042-7158.1987.tb06975.x
Item in Clipboard
Comparative Study
Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1 alpha production and on bile salt-induced changes in gastric mucosal function
J Pharm Pharmacol.
1987 Sep.
Abstract
The effect of nabumetone on rat gastric mucosal cyclooxygenase activity ex-vivo and in-vitro has been compared with that of indomethacin. Nabumetone was less potent and less active in inhibiting the production of gastric mucosal 6-keto-PGF1 alpha compared with indomethacin either ex-vivo or in-vitro. Anti-inflammatory doses of nabumetone failed to enhance bile salt-induced gastric erosion or mucosal permeability to dextran whereas indomethacin significantly enhanced gastric erosion and increased dextran permeability. These results suggest that nabumetone fails to promote gastric damage or increase permeability because of minimal effects on gastric mucosal cyclooxygenase.
Similar articles
-
Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.Dig Dis Sci. 1992 Dec;37(12):1847-52. doi: 10.1007/BF01308078. Dig Dis Sci. 1992. PMID: 1473433
-
Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.Agents Actions. 1992;Spec No:C82-3. Agents Actions. 1992. PMID: 1442340
-
Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.Prostaglandins Leukot Essent Fatty Acids. 1990 Nov;41(3):195-9. doi: 10.1016/0952-3278(90)90090-8. Prostaglandins Leukot Essent Fatty Acids. 1990. PMID: 2281122
-
The unique pharmacologic profile of nabumetone.J Rheumatol Suppl. 1992 Nov;36:13-9. J Rheumatol Suppl. 1992. PMID: 1474529 Review.
-
NSAIDS and the microcirculation of the stomach.Gastroenterol Clin North Am. 1996 Jun;25(2):299-315. doi: 10.1016/s0889-8553(05)70248-x. Gastroenterol Clin North Am. 1996. PMID: 9229574 Review.
Cited by
-
Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat. Differentiation of effects between nabumetone and etodolac.Dig Dis Sci. 1994 Mar;39(3):601-8. doi: 10.1007/BF02088349. Dig Dis Sci. 1994. PMID: 8131699
-
Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.Dig Dis Sci. 1992 Dec;37(12):1847-52. doi: 10.1007/BF01308078. Dig Dis Sci. 1992. PMID: 1473433
-
Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution?Drugs. 1990;40 Suppl 5:16-24. doi: 10.2165/00003495-199000405-00005. Drugs. 1990. PMID: 2081487
-
Effects of the prodrug nabumetone, and its active metabolite, 6-MNA, on human and rat gastric mucosal prostanoids and platelet function.Drugs. 1990;40 Suppl 5:53-6. doi: 10.2165/00003495-199000405-00013. Drugs. 1990. PMID: 2081494 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
